510(k) device
Duet External Drainage and Monitoring System (EDMS)
Medtronic Neurosurgery · External Cerebrospinal Fluid (Csf) Diversion (PCB, Class II) · First FDA decision Oct 24, 2024, newest Oct 24, 2024Hydrocephalus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
20
Naming "Duet"
MAUDE reports
0
Brand "Duet", since 2015
PubMed studies
789
Mentioning "Duet"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Duet External Drainage and Monitoring System (EDMS)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Duet", any status and sponsor, newest update first.
- Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET TrialPivotal-lookingRecruiting
Resonova (Shanghai) Medtech LimitedNot on our public-company list
NCT07648693 · 240 participants (planned) · Start Oct 31, 2025 · Primary completion Sep 30, 2026
Device: CHORDS® Cerebral Protection System; Sentinel Cerebral Protection System · For: Transcatheter Aortic Valve Replacement (TAVR); Cerebral Vascular Accident (CVA)/Stroke
Sites: Bengbu, China; Hefei, China; Beijing, China · 15 sites in all
Siriraj HospitalAcademic, hospital or other
NCT06204276 · 40 participants · Start Jan 20, 2024 · Primary completion Nov 30, 2024
Device: Experimental: Asymmetrical high-flow nasal cannula; Active comparator: Conventional high-flow nasal cannula · For: Acute Hypoxemic Respiratory Failure; Acute Hypercapnic Respiratory Failure
Sites: Bangkok Noi, Thailand
Larissa University HospitalAcademic, hospital or other
NCT05829083 · 50 participants (planned) · Start Jul 18, 2023 · Primary completion Dec 1, 2025
Device: Asymmetric nasal cannula - DUET; Conventional nasal high flow cannula · For: COPD Exacerbation; Hypercapnia; COPD
Sites: Athens, Greece; Larissa, Greece
17 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Duet", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PCB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Duet"[tiab]. The summary above synthesizes these.
- Etravirine.
Deeks ED, Keating GM · Drugs · 2008Review
- A duet of T6SS effectors.
Zhu L, Shen X · Cell Host Microbe · 2025Comment
- Neurophysiological coordination of duet singing.
Coleman MJ, Day NF, Rivera-Parra P, et al. · Proc Natl Acad Sci U S A · 2021Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Expanding the GPCR-RAMP interactome.
Kotliar IB, Bendes A, Dahl L, et al. · bioRxiv · 2023Preprint
- Duet of humoral and cellular immunity for conquering HCV.
Yu H, Shin EC · Hepatology · 2024Research Support, Non-U.S. Gov't, Comment
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.
Trachtman H, Nelson P, Adler S, et al. · J Am Soc Nephrol · 2018Clinical Trial, Phase II, Multicenter Study
- Duet playing in dementia care: a new therapeutic music technology.
Nicol J, Loehr J, Christensen J, et al. · Disabil Rehabil Assist Technol · 2024Research Support, Non-U.S. Gov't
- Reversible Multifocality Achieved Through Polypseudophakia.
Baur ID, Labuz G, Yildirim TM, et al. · Klin Monbl Augenheilkd · 2023
- [Duet procedure to achieve reversible trifocality].
Khoramnia R, Yildirim TM, Son HS, et al. · Ophthalmologe · 2020Review
- Duet: SNP-assisted structural variant calling and phasing using Oxford nanopore sequencing.
Zhou Y, Leung AW, Ahmed SS, et al. · BMC Bioinformatics · 2022
- Perfect duet: Dual recombinases improve genetic resolution.
Li H, Weng W, Zhou B · Cell Prolif · 2023Review
- The PVT1-MYC duet in cancer.
Tseng YY, Bagchi A · Mol Cell Oncol · 2015
Other devices of this type
Also filed under product code PCB.
- Medtronic DUET External Drainage and Monitoring SystemMedtronic Neurosurgery · De Novo 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.